SPRY - ARS Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.50
DETAILS
HIGH:
$26.00
LOW:
$25.00
MEDIAN:
$25.50
CONSENSUS:
$25.50
UPSIDE:
221.16%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-01-02 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | 875,000 | $11.49 | $10.1M |
| 2026-01-02 | Chakma Justin | officer: Chief Business Officer | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Scott Kathleen D. | officer: Chief Financial Officer | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Karas Eric | officer: Chief Commercial Officer | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | 875,000 | $11.49 | $10.1M |
| 2026-01-02 | Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Fitzpatrick Alexander A | officer: Chief Legal Officer | A-Award | 240,000 | $11.49 | $2.8M |
| 2026-01-02 | Dorsey Brian | officer: Chief Operating Officer | A-Award | 240,000 | $11.49 | $2.8M |
| 2025-11-13 | Dorsey Brian | officer: Chief Operating Officer | SELL | 21,828 | $8.71 | $190K |
| 2025-11-12 | Shah Pratik | director | G-Gift | 250,000 | -- | -- |
| 2025-11-12 | Shah Pratik | director | G-Gift | 100,000 | -- | -- |
| 2025-11-13 | Dorsey Brian | officer: Chief Operating Officer | M-Exempt | 21,828 | $0.64 | $14K |
| 2025-11-12 | Chakma Justin | officer: Chief Business Officer | SELL | 136,380 | $8.86 | $1.2M |
| 2025-11-12 | Chakma Justin | officer: Chief Business Officer | SELL | 30,000 | $8.91 | $267K |
| 2025-11-12 | Chakma Justin | officer: Chief Business Officer | M-Exempt | 30,000 | $0.84 | $25K |
| 2025-08-21 | Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | SELL | 50,000 | $14.49 | $724K |
| 2025-08-21 | Scott Kathleen D. | officer: Chief Financial Officer | M-Exempt | 12,500 | $1.50 | $19K |
| 2025-08-21 | Scott Kathleen D. | officer: Chief Financial Officer | SELL | 12,500 | $15.00 | $188K |
| 2025-08-19 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | SELL | 12,344 | $14.03 | $173K |
| 2025-08-20 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | SELL | 37,656 | $14.09 | $531K |
| 2025-07-01 | Karas Eric | officer: Chief Commercial Officer | M-Exempt | 15,000 | $1.50 | $22K |
| 2025-07-01 | Karas Eric | officer: Chief Commercial Officer | SELL | 15,000 | $16.99 | $255K |
| 2025-06-27 | Flynn James E | 10 percent owner | SELL | 370,074 | $18.46 | $6.8M |
| 2025-06-25 | Kelly Michael | director | A-Award | 30,000 | $17.26 | $518K |